You are using an outdated browser. Please upgrade your browser to improve your experience.
Model for End-Stage Liver Disease (MELD) Score

Model for end-stage liver disease score is a model based on serum bilirubin, creatinine, and INR and is useful to predict the three month mortality risk in patients with chronic liver disease

Model for end-stage liver disease score is a model based on serum bilirubin, creatinine, and INR and is useful to predict the three month mortality risk in patients with chronic liver disease

Model for End-Stage Liver Disease (MELD) Score

by Murthy Chamarthy
Model for End-Stage Liver Disease (MELD) Score
Model for End-Stage Liver Disease (MELD) Score
Model for End-Stage Liver Disease (MELD) Score

What is it about?

Model for end-stage liver disease score is a model based on serum bilirubin, creatinine, and INR and is useful to predict the three month mortality risk in patients with chronic liver disease. It was initially developed for predicting the mortality subsequent to elective TIPS shunt placement. MELD was subsequently adopted by UNOS for prioritization of organ allocation to patients awaiting liver transplantation, with additional scoring points based on MELD exceptions and eligible waiting period. It has also been proven to be useful in predicting mortality and outcomes for surgical procedures in cirrhotic patients, and in acute alcoholic hepatitis, hepatorenal syndrome and acute variceal hemorrhage. Several modifications were proposed to MELD score such as addition of serum sodium which might provide better risk stratification. This application implements the MELD scoring algorithm and provides a prognostic score based on the user provided input.

Model for End-Stage Liver Disease (MELD) Score

App Details

Version
1.0
Rating
NA
Size
11Mb
Genre
Medical Education
Last updated
February 10, 2015
Release date
February 10, 2015
More info

Model for End is FREE but there are more add-ons

  • $4.99

    Remove Ads

App Store Description

Model for end-stage liver disease score is a model based on serum bilirubin, creatinine, and INR and is useful to predict the three month mortality risk in patients with chronic liver disease. It was initially developed for predicting the mortality subsequent to elective TIPS shunt placement. MELD was subsequently adopted by UNOS for prioritization of organ allocation to patients awaiting liver transplantation, with additional scoring points based on MELD exceptions and eligible waiting period. It has also been proven to be useful in predicting mortality and outcomes for surgical procedures in cirrhotic patients, and in acute alcoholic hepatitis, hepatorenal syndrome and acute variceal hemorrhage. Several modifications were proposed to MELD score such as addition of serum sodium which might provide better risk stratification. This application implements the MELD scoring algorithm and provides a prognostic score based on the user provided input.

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to [email protected] and your information will be removed.